Utility of the WHO-five well-being index as a screening tool for depression in Parkinson's disease

Movement Disorders

Volumn 25, Issue 6, 2010, Pages 777-783

  Schneider, Christine B ^a   Pilhatsch, Maximilian ^a   Rifati, Martina ^b   Jost, Wolfgang H ^b   Wodarz, Franziska ^c   Ebersbach, Georg ^c   Djundja, Daniela ^d   Fuchs, Gerd ^d   Gies, Arne ^e   Odin, Per ^e   Reifschneider, Gerd ^f   Wolz, Martin ^a   Bottesi, Antonia ^a   Bauer, Michael ^a   Reichmann, Heinz ^e   Storch, Alexander ^e  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

^c Movement Disorder Clinic   (Germany)

^d Parkinson Clinic Wolfach   (Germany)

^e Zentralkrankenhaus Reinkenheide ^*

^f Neuro Centrum Odenwald   (Germany)

Author keywords

BDI 1A; Depression; Parkinson's disease; Screening; Validity; WHO five well being index

Indexed keywords

ADULT; AGED; ARTICLE; DEPRESSION; DIAGNOSTIC ACCURACY; DYSTHYMIA; FEMALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; NEUROLOGIC DISEASE; PARKINSON DISEASE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SCREENING TEST; UNIFIED PARKINSON DISEASE RATING SCALE; VALIDITY; WELLBEING; WORLD HEALTH ORGANIZATION; WORLD HEALTH ORGANIZATION FIVE WELBEING INDEX;

EID: 77951831436     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.22985     Document Type: Article

References (29)

1. Veazey C, Aki SO, Cook KF, Lai EC, Kunik ME. Prevalence and treatment of depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2005;17:310-323. (Pubitemid 46179293)
2. Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 2000;69:308-312.
3. Yamamoto M. Depression in Parkinson's disease: its prevalence, diagnosis, and neurochemical background. J Neurol 2001;248(Suppl 3):III5-III11. (Pubitemid 32972396)
4. Tandberg E, Larsen JP, Aarsland D, Cummings JL. The occurrence of depression in Parkinson's disease. A community-based study. Arch Neurol 1996;53:175-179.
5. Marsh L, McDonald WM, Cummings J, Ravina B. Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH work group. Mov Disord 2006;21:148-158.
6. Brown RG, MacCarthy B, Gotham AM, Der GJ, Marsden CD. Depression and disability in Parkinson's disease: a follow-up of 132 cases. Psychol Med 1988;18:49-55. (Pubitemid 18071632)
7. Hoogendijk WJ, Sommer IE, Tissingh G, Deeg DJ, Wolters EC. Depression in Parkinson's disease. The impact of symptom overlap on prevalence. Psychosomatics 1998;39:416-421.
8. Shulman LM, Taback RL, Rabinstein AA, Weiner WJ. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 2002;8:193-197.
9. Schrag A, Barone P, Brown RG, et al. Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord 2007;22:1077-1092. (Pubitemid 47067217)
10. Leentjens AF, Verhey FR, Luijckx GJ, Troost J. The validity of the Beck depression inventory as a screening and diagnostic instrument for depression in patients with Parkinson's disease. Mov Disord 2000;15:1221-1224.
11. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
12. Lowe B, Spitzer RL, Grafe K, et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord 2004;78:131-140. (Pubitemid 38045472)
13. Saipanish R, Lotrakul M, Sumrithe S. Reliability and validity of the Thai version of the WHO-five wellbeing index in primary care patients. Psychiatry Clin Neurosci 2009;63:141-146.
14. Henkel V, Mergl R, Coyne JC, Kohnen R, Moller HJ, Hegerl U. Screening for depression in primary care: will one or two items suffice? Eur Arch Psychiatry Clin Neurosci 2004;254:215-223.
15. Henkel V, Mergl R, Kohnen R, Allgaier AK, Moller HJ, Hegerl U. Use of brief depression screening tools in primary care: consideration of heterogeneity in performance in different patient groups. Gen Hosp Psychiatry 2004;26:190-198. (Pubitemid 38581924)
16. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
17. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992;55:181-184.
18. Cockrell JR, Folstein MF. Mini-mental state examination (MMSE). Psychopharmacol Bull 1988;24:689-692.
19. Fahn S, Elton RL, Committee UD. The unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, editors. Recent developments in Parkinson's disease. Florham Park: Macmillan Healthcare Information; 1987. p 153-163, 293-304.
20. Richter P, Werner J, Heerlein A, Kraus A, Sauer H. On the validity of the Beck depression inventory. A review. Psychopathology 1998;31:160-168.
21. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59 (Suppl 20):22-33; quiz 34-57. (Pubitemid 29001829)
22. Sheehan D, Lecrubier Y, Harnett-Sheehan K, et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to SCID-P and its reliability. Eur Psychiatry 1997;12:232-241. (Pubitemid 27298916)
23. Simel DL, Samsa GP, Matchar DB. Likelihood ratios with confidence: sample size estimation for diagnostic test studies. J Clin Epidemiol 1991;44:763-770.
24. Pedersen KF, Larsen JP, Aarsland D. Validation of the unified parkinson's disease rating scale (UPDRS) section I as a screening and diagnostic instrument for apathy in patients with Parkinson's disease. Parkinsonism Relat Disord 2008;14:183-186. (Pubitemid 351458418)
25. Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. Oxford: Oxford University Press; 1995.
26. Visser M, Leentjens AF, Marinus J, Stiggelbout AM, van Hilten JJ. Reliability and validity of the Beck depression inventory in patients with Parkinson's disease. Mov Disord 2006;21:668-672.
27. Holroyd S, Currie LJ, Wooten GF. Validity, sensitivity and specificity of the mentation, behavior and mood subscale of the UPDRS. Neurol Res 2008. (Pubitemid 352008708)
28. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development and validation of a short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995;4:241-248.
29. Chaudhuri KR, Martinez-Martin P, Schapira AH, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson's disease: the NMSQuest study. Mov Disord 2006;21:916-923. (Pubitemid 44184590)